284 related articles for article (PubMed ID: 33573698)
1. Barriers to completing colonoscopy after a positive fecal occult blood test.
Azulay R; Valinsky L; Hershkowitz F; Elran E; Lederman N; Kariv R; Braunstein B; Heymann A
Isr J Health Policy Res; 2021 Feb; 10(1):11. PubMed ID: 33573698
[TBL] [Abstract][Full Text] [Related]
2. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
[TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
4. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.
Paltiel O; Keidar Tirosh A; Paz Stostky O; Calderon-Margalit R; Cohen AD; Elran E; Valinsky L; Matz E; Krieger M; Yehuda AB; Jaffe DH; Manor O
J Med Screen; 2021 Mar; 28(1):25-33. PubMed ID: 32356670
[TBL] [Abstract][Full Text] [Related]
5. CRC Screening Results: Patient Comprehension and Follow-up.
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
Cancer Control; 2019; 26(1):1073274819825828. PubMed ID: 30704290
[TBL] [Abstract][Full Text] [Related]
6. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
[TBL] [Abstract][Full Text] [Related]
7. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
[TBL] [Abstract][Full Text] [Related]
8. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.
Almansoori A; Alzaabi M; Alketbi L
BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343
[TBL] [Abstract][Full Text] [Related]
10. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol.
Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S;
BMC Cancer; 2012 May; 12():182. PubMed ID: 22607726
[TBL] [Abstract][Full Text] [Related]
11. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
[TBL] [Abstract][Full Text] [Related]
12. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the management of positive fecal occult blood tests.
Rao SK; Schilling TF; Sequist TD
J Gen Intern Med; 2009 Mar; 24(3):356-60. PubMed ID: 19130147
[TBL] [Abstract][Full Text] [Related]
14. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
15. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
16. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
17. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
[TBL] [Abstract][Full Text] [Related]
18. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
[TBL] [Abstract][Full Text] [Related]
19. Colon Cancer Screening - Is It Time Yet?
Bhurgri H; Samiullah S
J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
